Literature DB >> 25172602

First outcome results after total knee and hip replacement from the Lithuanian arthroplasty register.

Sarūnas Tarasevičius1, Algimantas Cebatorius2, Rasa Valavičienė3, Justinas Stučinskas3, Linas Leonas3, Otto Robertsson4.   

Abstract

BACKGROUND AND
OBJECTIVE: In 2010, the Lithuanian Association of Arhtroplasty was established and on January 1, 2011, initiated a national study of all reoperations after total knee (TKR) and total hip replacement (THR) in Lithuania. The aim of the study was to investigate the revision rates after TKR and THR at two years follow-up.
MATERIALS AND METHODS: Lithuanian patients undergoing primary TKR and THR from January 1, 2011, to December 31, 2012, were included in the study. The patient, surgery and prosthetic implantation data were collected via internet database. For reoperations we recorded the reason and type of revision, primary implantation date. We analyzed implant survival rates using any revision as an endpoint on included primary procedures, performed until September 1, 2013.
RESULTS: The completeness of the register verified with state patients fund data reached 85% of all replacements. Out of 3823 primary TKR during the study period 25 revisions were performed with overall implant survival rate 99%. The main reason for knee revision was infections. During the inclusion period we registered 6072 primary THR and 149 revisions with overall implant survival rate 97%. Recurrent dislocation of prosthetic component was the main reason for hip revision. Significantly inferior survival results for femoral neck fracture patients were observed as compared with patients operated for osteoarthritis. Posterior approach as compared to others significantly affected inferior implant survival rates for femoral neck fracture patients.
CONCLUSIONS: The overall survival after total knee and hip replacements revealed a high treatment quality of this surgery in Lithuania.
Copyright © 2014 Lithuanian University of Health Sciences. Production and hosting by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Arthroplasty register; Revision; Total hip replacement; Total knee replacement

Mesh:

Year:  2014        PMID: 25172602     DOI: 10.1016/j.medici.2014.06.004

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  5 in total

1.  Contemporary dual-mobility cup regional and private register: methodology and results.

Authors:  André Ferreira; Jean-Louis Prudhon; Régis Verdier; Jean-Marc Puch; Loys Descamps; Guy Dehri; Marcel Remi; Jacques H Caton
Journal:  Int Orthop       Date:  2017-02-14       Impact factor: 3.075

2.  Short-term outcome after total hip arthroplasty using dual-mobility cup: report from Lithuanian Arthroplasty Register.

Authors:  Sarunas Tarasevicius; Alfredas Smailys; Kazimieras Grigaitis; Otto Robertsson; Justinas Stucinskas
Journal:  Int Orthop       Date:  2017-01-12       Impact factor: 3.075

3.  Comparison of dual mobility cup and other surgical construts used for three hundred and sixty two first time hip revisions due to recurrent dislocations: five year results from Lithuanian arthroplasty register.

Authors:  Justinas Stucinskas; Tomas Kalvaitis; Alfredas Smailys; Otto Robertsson; Sarunas Tarasevicius
Journal:  Int Orthop       Date:  2017-12-02       Impact factor: 3.075

4.  Inadequate evaluation and management of suspected -infections after TKA surgery in Lithuania: a retrospective study of 2,769 patients with 2-year follow-up.

Authors:  Egle Terteliene; Kazimieras Grigaitis; Otto Robertsson; Justinas Stucinskas; Sarunas Tarasevicius; Narunas Porvaneckas; Algirdas Venalis
Journal:  Acta Orthop       Date:  2019-05-09       Impact factor: 3.717

5.  Risk Factors for Revision After Early and Delayed Total Hip Arthroplasty Dislocation. An Analysis of Lithuanian Arthroplasty Register.

Authors:  Povilas Masionis; Tomas P Vileikis; Giedrius Kvederas; Valentinas Uvarovas; Igoris Šatkauskas; Tomas Sveikata; Jaunius Kurtinaitis
Journal:  Cureus       Date:  2021-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.